All In MedTech

Device Trial Radar · NCT06511141

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Sacral Neuromodulation for Male Overactive Bladder

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Oct 22, 2024

Primary completion

Dec 2027

Study completion Dec 2028

Sponsor

Lead sponsor
Axonics, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jul 19, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.

Conditions

  • Overactive Bladder
  • Urinary Urgency Incontinence
  • Benign Prostatic Hyperplasia
  • Prostate Cancer
  • Prostatectomy
  • Urinary Frequency

Interventions

  • Axonics SNM SystemDevice

    To assess clinical outcomes of the Axonics SNM System in the male OAB population.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse event reporting (Safety)Time frame: 6 months, 1 year
  2. Performance/Effectiveness - Reduction in UUI or UF episodesTime frame: 6 months, 1 year

Locations

23 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama · Recruiting

  • Urology Associates

    Fairhope, Alabama · Completed

  • Mayo Clinic

    Scottsdale, Arizona · Recruiting

20 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.